Loading...
SOLB logo

Solvay SAENXTBR:SOLB Voorraadrapport

Marktkapitalisatie €2.9b
Prijs aandeel
€27.64
€25.1
10.1% overgewaardeerd intrinsieke korting
1Y-4.6%
7D5.4%
1D
Portefeuillewaarde
Bekijk

Solvay SA

ENXTBR:SOLB Voorraadrapport

Marktkapitalisatie: €2.9b

SOLB Community Fair Values

Create Narrative

See what 46 others think this stock is worth. Follow their fair value or set your own to get alerts.

Solvay SA Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van hoogtepunten, dieptepunten en veranderingen in de aandelenkoersen voor Solvay
Historische aandelenkoersen
Huidige aandelenkoers€27.64
52 Week Hoogtepunt€30.56
52 Week Laag€23.54
Bèta0.25
1 maand verandering7.30%
3 maanden verandering12.18%
1 Jaar Verandering-4.56%
3 jaar verandering-72.40%
5 jaar verandering-74.37%
Verandering sinds IPO-0.45%

Recent nieuws en updates

Analyseartikel 21h

Solvay (ENXTBR:SOLB) Stock Could Be 8.8% Overvalued After European Patent Win

The European Patent Office has upheld Solvay (ENXTBR:SOLB)’s key European patent covering its soda ash purge stream recycling process after a challenge from WE Soda Ltd, putting the company’s intellectual property position firmly in focus for investors. See our latest analysis for Solvay. Solvay’s recent patent win comes at a time when the stock’s 7-day share price return of 5.98% and 30-day share price return of 4.12% sit against a 1-year total shareholder return that is down 3.84%, while...
Narratiefupdate Jun 11

SOLB: Rare Earth Supply Plans And Mixed Ratings Will Shape Fair Value Outlook

Narrative Update The analyst price target for Solvay is now set at €25.10. This move is supported by recent Street research, where analysts highlight the company’s rare earth capabilities and adjust targets in a €26 to €30 range, while fine tuning assumptions around discount rates, modest revenue declines, profit margins and future P/E expectations.
Narratiefupdate May 28

SOLB: Mixed Ratings And Higher P/E Assumptions Will Shape Fair Value Outlook

Solvay's analyst price target has been trimmed by about €0.40 to reflect slightly lower fair value and profit margin assumptions, even as analysts factor in a higher future P/E multiple based on recent research updates. Analyst Commentary The latest round of research on Solvay points to a mixed view, with some analysts trimming price targets while others see room for the stock to trade at higher levels relative to earnings.

Recent updates

Analyseartikel 21h

Solvay (ENXTBR:SOLB) Stock Could Be 8.8% Overvalued After European Patent Win

The European Patent Office has upheld Solvay (ENXTBR:SOLB)’s key European patent covering its soda ash purge stream recycling process after a challenge from WE Soda Ltd, putting the company’s intellectual property position firmly in focus for investors. See our latest analysis for Solvay. Solvay’s recent patent win comes at a time when the stock’s 7-day share price return of 5.98% and 30-day share price return of 4.12% sit against a 1-year total shareholder return that is down 3.84%, while...
Narratiefupdate Jun 11

SOLB: Rare Earth Supply Plans And Mixed Ratings Will Shape Fair Value Outlook

Narrative Update The analyst price target for Solvay is now set at €25.10. This move is supported by recent Street research, where analysts highlight the company’s rare earth capabilities and adjust targets in a €26 to €30 range, while fine tuning assumptions around discount rates, modest revenue declines, profit margins and future P/E expectations.
Narratiefupdate May 28

SOLB: Mixed Ratings And Higher P/E Assumptions Will Shape Fair Value Outlook

Solvay's analyst price target has been trimmed by about €0.40 to reflect slightly lower fair value and profit margin assumptions, even as analysts factor in a higher future P/E multiple based on recent research updates. Analyst Commentary The latest round of research on Solvay points to a mixed view, with some analysts trimming price targets while others see room for the stock to trade at higher levels relative to earnings.
Narratiefupdate Apr 19

SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook

Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others. Analyst Commentary Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance.
Narratiefupdate Apr 02

SOLB: Trimmed Expectations And Mixed Ratings Will Still Support Fair Value

Solvay's analyst price target has been trimmed by about €0.25, as analysts factor in softer revenue expectations, slightly higher margin assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research on Solvay points to a cautious stance, with several firms trimming price targets or downgrading ratings while a few still see upside at specific levels.
Narratiefupdate Mar 19

SOLB: Rare Earth Role Will Offset Execution Risks And Support Fair Value

Analysts have nudged Solvay's fair value estimate slightly lower to about €25.72 per share. This reflects a mix of reduced profit margin assumptions, a modestly lower discount rate, and updated external price targets that now cluster in the €22 to €28 range.
Narratiefupdate Mar 04

SOLB: Rare Earth Supply Role Will Temper Softer Outlook And Downgrades

Narrative Update on Solvay Our updated analyst price target for Solvay edges down slightly to €25.78 from €25.88. This reflects a modest recalibration of expected growth and margins, even as recent Street research has shifted targets in a tight €22 to €28 range with several downgrades and cautious P/E assumptions from analysts.
Narratiefupdate Feb 18

SOLB: Rare Earth Supply Role Will Offset Softer Outlook And Downgrades

Analysts have reduced their price target on Solvay to about €25.88 from roughly €26.44, reflecting a series of recent downgrades and slightly softer assumptions for revenue, margins and fair value multiples. Analyst Commentary Bullish Takeaways Bullish analysts still see upside to the current share price, with some targets such as €28 and €27 implying room for rerating if execution on cost discipline and portfolio focus holds up.
Narratiefupdate Feb 03

SOLB: Rare Earth Partnerships Will Counter Softer Outlook And Cautious Ratings

Analysts have trimmed their price targets on Solvay, with our fair value estimate moving from €27.19 to €26.44 as they factor in slightly softer revenue expectations, a higher discount rate, and lower assumed future P/E multiples, partly offset by firmer profit margin assumptions. Analyst Commentary Recent Street research on Solvay has leaned more cautious, with several firms lowering price targets and moving to more neutral or negative ratings as they reassess the risk and reward profile.
Narratiefupdate Jan 19

SOLB: Rare Earth Agreements Will Offset Softer Outlook At A Fair Price

Analysts have nudged their Solvay price target slightly lower to about €27.19 from about €27.27, reflecting updated views on slower revenue trends, a higher discount rate, better profit margins, and a lower future P/E assumption, alongside recent target cuts and rating changes from several research houses. Analyst Commentary Recent research opinions around Solvay cluster around cautious updates to price targets and ratings, with most commentary focusing on how current execution and growth expectations line up against existing valuations.
Narratiefupdate Jan 05

SOLB: Rare Earth Agreements Will Steady Execution Risks At A Fair Price

Analysts have trimmed their price target on Solvay to about €23.50, a modest reset that reflects slightly lower profit margin expectations while keeping fair value and P/E assumptions broadly in line with prior views. Analyst Commentary Recent research points to a slightly lower fair value marker for Solvay at about €23.50, which still sits close to prior assumptions on P/E and overall valuation.
Narratiefupdate Dec 14

SOLB: Rare Earth Agreements Will Offset Softer Outlook And Heightened Execution Risks

Analysts trimmed their fair value estimate for Solvay by about EUR 0.50 per share, reflecting slightly higher perceived risk and softer long term growth expectations, in line with a series of recent price target cuts across the Street. Analyst Commentary Recent Street updates reflect a cautious stance on Solvay, with a series of modest price target reductions signaling tempered expectations for both earnings growth and valuation upside.
Narratiefupdate Nov 29

SOLB: Near-Term Outlook Will Hinge On Margin Resilience Amid Industry Pressures

Solvay’s analyst price target was modestly reduced from €27.80 to €27.73. Analysts cite ongoing cautiousness around revenue growth and margin pressures, which are reflected in several recent downward revisions.
Narratiefupdate Nov 15

SOLB: Future Performance Will Depend On Profit Margin Recovery And Cost Discipline

Solvay's analyst price target was reduced from €28.70 to €27.80, as analysts cited a more cautious outlook on revenue growth and profit margins in recent research updates. Analyst Commentary Analyst sentiment toward Solvay has shifted in recent research updates, with several firms lowering their price targets and highlighting both positive and negative drivers that could influence the company’s near-term performance.
Narratiefupdate Oct 31

SOLB: Recent Macroeconomic Pressures Will Shape Outlook Amid Stable Fundamentals

Narrative Update on Solvay Solvay’s analyst price target has been lowered slightly, from €28.97 to €28.70, as analysts cite modestly higher discount rates and slightly weaker revenue growth outlooks in their recent updates. Analyst Commentary Recent updates from analysts have provided a nuanced view of Solvay's outlook, highlighting both areas of potential and ongoing challenges that may affect its future performance.
Narratiefupdate Oct 17

La Rochelle Expansion And Energy Transition Will Secure Future Success

Analysts have modestly reduced their price target for Solvay, lowering it by a small margin in response to recent Street research. The research cites softer profit margins and ongoing revenue pressures, resulting in updated targets between EUR 25.50 and EUR 27.
Narratiefupdate Oct 03

La Rochelle Expansion And Energy Transition Will Secure Future Success

Solvay's analyst price target has been revised downward by approximately EUR 0.80 per share. Analysts cite ongoing revenue pressure and updated profit margin forecasts to support the adjustment.
Narratiefupdate Sep 04

La Rochelle Expansion And Energy Transition Will Secure Future Success

Analysts have maintained a cautious outlook on Solvay due to persistent input cost inflation, margin pressure, and weak European demand, resulting in conservative earnings estimates and an unchanged consensus price target of €29.83. Analyst Commentary Cautious sentiment persists due to slower organic growth outlook in core businesses.
Analyseartikel Jan 24

Risks To Shareholder Returns Are Elevated At These Prices For Solvay SA (EBR:SOLB)

It's not a stretch to say that Solvay SA's ( EBR:SOLB ) price-to-sales (or "P/S") ratio of 0.6x right now seems quite...
Analyseartikel Jan 06

Solvay (EBR:SOLB) Will Pay A Dividend Of €0.679

The board of Solvay SA ( EBR:SOLB ) has announced that it will pay a dividend on the 22nd of January, with investors...
User avatar
Nieuw narratief Dec 25

Green River Expansion And Hydrogen Peroxide Licensing Propel Earnings Growth

Expansion of Green River facility and sustainability efforts position Solvay to benefit from future revenue growth and attract environmentally conscious customers.
Analyseartikel Dec 21

Solvay's (EBR:SOLB) Dividend Will Be €0.679

Solvay SA's ( EBR:SOLB ) investors are due to receive a payment of €0.679 per share on 22nd of January. The dividend...
Analyseartikel Oct 17

Solvay SA (EBR:SOLB) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Solvay SA ( EBR:SOLB ) shareholders would be excited to see that the share price has had a great month, posting a 25...
Analyseartikel Sep 18

Are Investors Undervaluing Solvay SA (EBR:SOLB) By 43%?

Key Insights Solvay's estimated fair value is €57.91 based on 2 Stage Free Cash Flow to Equity Solvay is estimated to...
Analyseartikel Aug 28

Solvay SA's (EBR:SOLB) Share Price Could Signal Some Risk

It's not a stretch to say that Solvay SA's ( EBR:SOLB ) price-to-sales (or "P/S") ratio of 0.6x right now seems quite...
Analyseartikel Aug 08

Solvay's (EBR:SOLB) Earnings May Just Be The Starting Point

Solvay SA's ( EBR:SOLB ) earnings announcement last week was disappointing for investors, despite the decent profit...
Analyseartikel Jul 14

Solvay (EBR:SOLB) Has A Somewhat Strained Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel Jun 14

Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Solvay fair value estimate is €50.62 Current share price of...
Analyseartikel May 29

Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?

While Solvay SA ( EBR:SOLB ) might not have the largest market cap around , it led the ENXTBR gainers with a relatively...
Analyseartikel Apr 24

Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Solvay SA ( EBR:SOLB ) shareholders have had their patience rewarded with a 26% share price jump in the last month...
Analyseartikel Mar 10

Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market

Solvay SA's ( EBR:SOLB ) price-to-earnings (or "P/E") ratio of 2.3x might make it look like a strong buy right now...
Analyseartikel Nov 20

Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?

Key Insights Solvay's estimated fair value is €144 based on 2 Stage Free Cash Flow to Equity Current share price of...
Analyseartikel Nov 06

Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13

Solvay SA ( EBR:SOLB ) will increase its dividend from last year's comparable payment on the 17th of January to €1.13...
Analyseartikel Nov 02

The Return Trends At Solvay (EBR:SOLB) Look Promising

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Analyseartikel Oct 19

Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Rendement voor aandeelhouders

SOLBBE ChemicalsBE Markt
7D5.4%6.7%1.1%
1Y-4.6%14.7%23.4%

Rendement versus industrie: SOLB presteerde slechter dan de Belgian Chemicals -sector, die het afgelopen jaar een rendement van 14.7 % opleverde.

Rendement versus markt: SOLB presteerde slechter dan Belgian Market, dat het afgelopen jaar een rendement van 23.4 % opleverde.

Prijsvolatiliteit

Is SOLB's price volatile compared to industry and market?
SOLB volatility
SOLB Average Weekly Movement4.1%
Chemicals Industry Average Movement5.5%
Market Average Movement4.1%
10% most volatile stocks in BE Market7.7%
10% least volatile stocks in BE Market2.6%

Stabiele aandelenkoers: SOLB heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de Belgian markt.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van SOLB is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
18638,400Philippe Kehrenwww.solvay.com

Solvay SA levert wereldwijd basischemicaliën en hoogwaardige chemicaliën. Het bedrijf houdt zich bezig met de productie van natriumcarbonaat of natriumcarbonaat dat wordt gebruikt in glas voor de bouw, zonnepanelen, glazen verpakkingen, verpakkingen, lithium-ionbatterijen voor elektrische voertuigen en voor detergenten en chemicaliën; en natriumbicarbonaat dat wordt gebruikt voor voeding en diervoeding, rookgasbehandeling en gezondheidszorg. Het biedt ook waterstofperoxide dat wordt gebruikt voor bleken, decontaminatie, desinfectie en antiseptische doeleinden in industrieën, waaronder pulp en papier, textiel, water en voedsel, evenals in halfgeleiders, fotovoltaïsche, stedelijke mijnbouw en batterijsectoren; en dient als tussenproduct voor de productie van chemicaliën, zoals propyleenoxide en caprolactam.

Solvay SA Samenvatting

Hoe verhouden de winst en inkomsten van Solvay zich tot de beurswaarde?
SOLB fundamentele statistieken
Marktkapitalisatie€2.89b
Inkomsten(TTM)-€25.00m
Inkomsten(TTM)€4.65b
0.6x
P/S-verhouding
-115.7x
Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
SOLB resultatenrekening (TTM)
Inkomsten€4.65b
Kosten van inkomsten€3.63b
Brutowinst€1.02b
Overige uitgaven€1.04b
Inkomsten-€25.00m

Laatst gerapporteerde inkomsten

Mar 31, 2026

Volgende inkomensdatum

Jul 29, 2026

Winst per aandeel (EPS)-0.24
Brutomarge21.89%
Nettowinstmarge-0.54%
Schuld/Eigen Vermogen Verhouding185.9%

Hoe presteerde SOLB op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

8.8%
Huidig dividendrendement
-1,016%
Uitbetalingsratio

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/06/17 14:02
Aandelenkoers aan het einde van de dag2026/06/17 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Solvay SA wordt gevolgd door 37 analisten. 10 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Katie RichardsBarclays
James StewartBarclays
Andreas HeineBarclays